1. Home
  2. ENVB vs BAOS Comparison

ENVB vs BAOS Comparison

Compare ENVB & BAOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENVB
  • BAOS
  • Stock Information
  • Founded
  • ENVB 1994
  • BAOS 2018
  • Country
  • ENVB United States
  • BAOS China
  • Employees
  • ENVB N/A
  • BAOS N/A
  • Industry
  • ENVB Biotechnology: Pharmaceutical Preparations
  • BAOS Business Services
  • Sector
  • ENVB Health Care
  • BAOS Consumer Discretionary
  • Exchange
  • ENVB Nasdaq
  • BAOS Nasdaq
  • Market Cap
  • ENVB 3.2M
  • BAOS 2.9M
  • IPO Year
  • ENVB N/A
  • BAOS 2021
  • Fundamental
  • Price
  • ENVB $1.28
  • BAOS $2.02
  • Analyst Decision
  • ENVB Strong Buy
  • BAOS
  • Analyst Count
  • ENVB 1
  • BAOS 0
  • Target Price
  • ENVB $10.00
  • BAOS N/A
  • AVG Volume (30 Days)
  • ENVB 42.6K
  • BAOS 54.9K
  • Earning Date
  • ENVB 05-19-2025
  • BAOS 05-19-2025
  • Dividend Yield
  • ENVB N/A
  • BAOS N/A
  • EPS Growth
  • ENVB N/A
  • BAOS N/A
  • EPS
  • ENVB N/A
  • BAOS N/A
  • Revenue
  • ENVB N/A
  • BAOS $624,087.00
  • Revenue This Year
  • ENVB N/A
  • BAOS N/A
  • Revenue Next Year
  • ENVB N/A
  • BAOS N/A
  • P/E Ratio
  • ENVB N/A
  • BAOS N/A
  • Revenue Growth
  • ENVB N/A
  • BAOS N/A
  • 52 Week Low
  • ENVB $1.01
  • BAOS $1.44
  • 52 Week High
  • ENVB $222.75
  • BAOS $13.66
  • Technical
  • Relative Strength Index (RSI)
  • ENVB 31.74
  • BAOS 50.34
  • Support Level
  • ENVB $1.23
  • BAOS $1.75
  • Resistance Level
  • ENVB $1.40
  • BAOS $2.32
  • Average True Range (ATR)
  • ENVB 0.09
  • BAOS 0.20
  • MACD
  • ENVB 0.15
  • BAOS 0.04
  • Stochastic Oscillator
  • ENVB 48.15
  • BAOS 61.54

About ENVB Enveric Biosciences Inc.

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

About BAOS Baosheng Media Group Holdings

Baosheng Media Group Holdings Ltd operates as a V-log streaming marketing service provider. The firm offers comprehensive marketing solutions. Its services are Internet effect marketing, V-log or short video streaming marketing including content production and operation, e-commerce marketing, original big data platform system service, and AI technology. It provides one-stop and full-link deep customized marketing solutions for partners. Baosheng Group is also a core agency of domestic Internet companies such as Tencent, Alibaba, Bytedance, and Kuaishou, with performing channel marketing services, technologies, and applications.

Share on Social Networks: